$BHC Income Statement | Understand Stock

$BHC

$6.31 -$0.04 (0.63%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenues
Product sales
Other revenues
Total revenues
Expenses
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues
Product sales
Other revenues
Selling, general and administrative
Research and development
Amortization of intangible assets
Goodwill impairments
Asset impairments
Restructuring, integration and separation costs
Other expense, net
Total expenses
Operating income
Interest income
Interest expense
Foreign exchange and other
Income (loss) before income taxes
Provision for income taxes
Net income (loss)
Net loss attributable to noncontrolling interest
Net income (loss) attributable to Bausch Health Companies Inc.
Earnings (loss) per share attributable to Bausch Health Companies Inc.
Basic (in dollars per share)
Diluted (in dollars per share)
Weighted-average common shares
Basic (in shares)
Diluted (in shares)

Comments